Improving Diagnosis of Migraine and Cluster Headache
  • CE

Source: Medical Minute
Improving Diagnosis and Care of Primary Headache Disorders With New Targeted Therapies
Learn about signs and symptoms, clinical presentation, and differential diagnosis criteria for primary headache disorders, migraine and cluster headache.
person default
Calli Cook, DNP, APRN, FNP-C, FAANP
person default
Jessica Kratz, MSPA, PA-C, AQH
Nurse Practitioners: 0.5 AANP contact hours
Released: December 22, 2020 Expiration: December 31, 2021

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Summarize how a diagnosis for migraine is established in clinical practice
  • Summarize how a diagnosis for cluster headache is established in clinical practice

Acknowledgements

Provided by the American Association of Nurse Practitioners (AANP)
Contact Info

AANP CE Center Manager
CECenter@aanp.org

Produced in collaboration with
Supported by an educational grant from
Lilly

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Information on this Educational Activity

Faculty

Calli Cook, DNP, APRN, FNP-C, FAANP

Clinical Assistant Professor
Emory University, NHWSON
Nurse Practitioner
Emory Brain Health Center
Atlanta, Georgia

Calli Cook, DNP, APRN, FNP-C, FAANP, has disclosed that she has received consulting fees from Allergan.
Jessica Kratz, MSPA, PA-C, AQH

Neurology Physician Assistant
Minneapolis, Minnesota

Jessica Kratz, MSPA, PA-C, AQH, has no relevant conflicts of interest to report.

Staff

Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Anne Roc, PhD
Director, Scientific Services
Anne Roc, PhD, has no relevant conflicts of interest to report.
Kiran D. Mir-Hudgeons, PhD

Manager, Editorial Operations

Kiran D. Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.
Taryn O'Loughlin Gross, PhD

Editorial Contributor

Taryn O’Loughlin Gross, PhD, has disclosed that she has received fees for non-CME services from Baudax Bio, Braeburn Inc., and Salix Pharmaceuticals.

Target Audience

This initiative is intended for nurse practitioners and physician assistants involved in managing patients with migraine.

Goal

The goal of this activity is to increase the knowledge and competence of nurse practitioners and physician assistants to recognize, diagnose, refer, and manage patients with migraine and cluster headaches.

Accreditation Information

This activity was developed through a partnership between American Association of Nurse Practitioners (AANP) and the American Academy of PAs (AAPA).

This activity is approved for 0.50 contact hour(s) of continuing education by the American Association of Nurse Practitioners. Activity ID# 20114637. This activity was planned in accordance with AANP Accreditation Standards and Policies.

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid from 12/22/2020 to 12/31/2021. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-201559.

Program Medium

This program has been made available online.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue